| Revenues | | 5,486.00 | 5,174.00 | 5,084.00 | 5,243.07 |
| Cost Of Revenue | | 3,469.00 | 3,243.00 | 3,177.00 | 3,285.10 |
| | 884.00 | - | - | - |
| Selling, General, and Administrative | | 884.00 | - | - | - |
| Operating Income/Loss | | 1,229.00 | 1,182.00 | 1,183.00 | 1,188.47 |
| Nonoperating Income/Loss | | -11.00 | -12.00 | -42.00 | -18.16 |
| Income/Loss From Equity Method Investments | | 53.00 | 51.00 | 58.00 | 52.24 |
| Income/Loss From Continuing Operations Before Tax | | 1,119.00 | 1,064.00 | 1,040.00 | 1,071.14 |
| Income Tax Expense/Benefit, Deferred | | 2.00 | -12.00 | 3.00 | -49.96 |
| Income Tax Expense/Benefit | | 215.00 | 219.00 | 232.00 | 147.51 |
| | 904.00 | 845.00 | 808.00 | 923.64 |
| Available To Common Stockholders, Basic | | 904.00 | 845.00 | 808.00 | 923.17 |
| Attributable To Noncontrolling Interest | 1.00 | - | - | - | 0.47 |
PH
